The Oncology Institute Inc. share price logo

The Oncology Institute Inc.

NASDAQ: TOI

Small Cap

$5.26

-0.40

(-6.98%)

as on

The Oncology Institute Inc. Stock Performance

as on July 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.18
    $5.87
    downward going graph

    1.52%

    Downside

    11.60%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.32
    $6.67
    downward going graph

    55.89%

    Downside

    26.81%

    Upside

    downward going graph

The Oncology Institute Inc. share price movements today

Previous Close
$5.66
Open
$5.63
Volume
3.1M
Day's Low - High
$5.18 - $5.87
52 Week Low - High
$2.32 - $6.67

The Oncology Institute Inc. Historical Returns

1 Month Return
+ 7.81 %
3 Month Return
+ 59.89 %
1 Year Return
+ 55.07 %
3 Year Return
+ 652.66 %
5 Year Return
0 %

The Oncology Institute Inc. Stock Fundamentals & Key Indicators

Check The Oncology Institute Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$624.9M

EPS (TTM)

-0.138

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-25.9M

Revenue (TTM)

545.8M

Profit Margin

-7.97%

Return On Equity TTM

-651.69%

The Oncology Institute Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of The Oncology Institute Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
The Oncology Institute Inc. image
The Oncology Institute Inc.
BUY$624.9MNANA-7.97%NA
Tenet Healthcare Corporation New image
Tenet Healthcare Corporation New
BUY$15.8B188.67%9.557.94%NA
DaVita Inc. image
DaVita Inc.
HOLD$14.9B94.03%22.675.65%NA
Encompass Health Corporation image
Encompass Health Corporation
BUY$10.9B38.04%18.8410.04%0.67%
HCA Healthcare Inc. image
HCA Healthcare Inc.
BUY$80.7B72.83%12.538.89%0.75%
See all

Stock Returns calculator for The Oncology Institute Inc. Stock including INR - Dollar returns

The The Oncology Institute Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

The Oncology Institute Inc. investment value today

Current value as on today

₹1,61,644

Returns

₹61,644

(+61.64%)

Returns from The Oncology Institute Inc. Stock

₹44,110 (+44.11%)

Dollar Impact

₹17,534 (+17.53%)

Analyst Recommendation on The Oncology Institute Inc. Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for The Oncology Institute Inc.. Average target price of $8.4

The Oncology Institute Inc. Share Price Target

Get share price movements and forecasts by analysts on The Oncology Institute Inc..

What analysts predicted

37.38%UPSIDE

Target Price

$8.4

Current Price

$5.26

Analyzed by

5 Analysts

Target

$8.40

The Oncology Institute Inc. target price $8.4, a slight upside of 37.38% compared to current price of $5.26. According to 5 analysts rating.

Indian Investors' Interest in The Oncology Institute Inc. Stock

Search interest for The Oncology Institute Inc. Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-6% versus previous 30 day period

The Oncology Institute Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
85
94
98
99
100
104
119
136
141
147
Gross Profit
14
11
13
14
14
17
17
18
22
21
Operating Income
-15
-17
-16
-13
-11
-9
-11
-8
-6
-6
EBITDA
-13
-16
-11
-12
-10
-12
-13
-12
-3
1
Interest Expense
1
1
2
2
1
5
1
1
1
1
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-19
-19
-15
-16
-13
-19
-17
-16
-7
-2
Income Tax Expense
0
0
-2
-
3
-
0
-
-
-
Net Income
-18
-19
-15
-16
-13
-19
-17
-16
-7
-2
Net Profit Margin
-21.86%
-21.01%
-15.70%
-16.13%
-13.15%
-18.76%
-14.20%
-12.09%
-5.29%
-1.69%

The Oncology Institute Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
113
155
187
203
252
324
393
502
Gross Profit
26
29
36
40
52
59
53
76
Operating Income
4
-2
-8
-45
-81
-77
-60
-36
EBITDA
9
0
-11
-42
-67
-54
-50
-42
Interest Expense
0
0
0
0
4
6
7
11
Depreciation
1
2
3
3
4
5
6
6
Income Before Tax
4
-2
-14
-11
0
-83
-64
-60
Income Tax Expense
0
1
0
0
0
0
-
0
Net Income
3
-4
-14
-10
0
-83
-64
-60
Net Profit Margin
3.49%
-2.59%
-7.64%
-5.38%
0.06%
-25.62%
-16.44%
-12.06%

The Oncology Institute Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-16
-12
-16
-13
-19
-17
-16
28
-2
Operating Cash Flow
-15
-15
0
4
-4
-10
-12
3
-2
Investing Cash Flow
19
18
10
-1
0
-1
0
-1
-1
Financing Cash Flow
0
-2
0
0
-4
1
10
3
0
Change in Cash
2
0
10
2
-9
-9
-2
5
-3

The Oncology Institute Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-14
-10
0
-83
-53
-60
Operating Cash Flow
3
0
-32
-61
-36
-26
-24
Investing Cash Flow
-1
-8
-12
-131
62
46
-3
Financing Cash Flow
0
11
154
92
-6
-3
11
Change in Cash
2
3
109
-101
19
16
-16

Global Institutional Holdings in The Oncology Institute Inc.

Funds
Holdings
Kanen Wealth Management LLC
2.78%
Wexford Capital LP
1.71%
TIFF Advisory Services Inc
3.89%
Citadel Advisors Llc
0.61%
Arrowstreet Capital Limited Partnership
0.42%
See all

The Oncology Institute Inc. News & Key Events

  • img

    Today's Timeline - 07 July

    Tue, 06:30 PM

    -

    Oncology Institute repays $86 million convertible note with new $75 million term loan from OrbiMed, enhancing liquidity and extending debt maturities.

Insights on The Oncology Institute Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 21 quarters, 48.57M → 147.44M (in $), with an average increase of 5.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TOI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, TOI stock has moved up by 59.9%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, -19.58M → -2.49M (in $), with an average increase of 84.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, DaVita Inc. has given 61.5% return, outperforming this stock by 6.4%

About The Oncology Institute Inc.

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
OrganisationThe Oncology Institute Inc.
Headquarters18000 Studebaker Road, Cerritos, CA, United States, 90703
IndustryMedical Care Facilities
CEODr. Daniel Virnich FACHE, M.B.A., M.D.
E-voting on sharesClick here to vote

Key Management of The Oncology Institute Inc.

Name

Title

Mr. Jordan McInerney

Chief Development Officer

Mr. Nolan Mariano

Chief People Officer

Mr. Robert Carter

Chief Financial Officer

Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.

Chief Medical Officer

Mr. Austin Lee

VP of Accounting & Controller

Mr. Rakesh Panda

Chief Information Officer

Ms. Minh Merchant

Chief Legal Officer

Mr. Mark Hueppelsheuser Esq.

General Counsel

Mr. Stephen Cella

Senior Vice President of Finance

Dr. Daniel Virnich FACHE, M.B.A., M.D.

CEO & Executive Director

FAQs

What is The Oncology Institute Inc. share price today?

The Oncology Institute Inc. share price today is $5.26 as on at the close of the market. The Oncology Institute Inc. share today touched a day high of $5.87 and a low of $5.18.

What is the 52 week high and 52 week low for The Oncology Institute Inc. share?

The Oncology Institute Inc. share touched a 52 week high of $6.67 on and a 52 week low of $2.32 on . The Oncology Institute Inc. stock price today i.e. is closed at $5.26,which is 21.14% down from its 52 week high and 126.72% up from its 52 week low.

What is The Oncology Institute Inc.'s market capitalisation today?

The Oncology Institute Inc. market capitalisation is $0.00T as on .

How to invest in The Oncology Institute Inc. Stock (TOI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for The Oncology Institute Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in The Oncology Institute Inc. Shares that will get you 0.2852 shares as per The Oncology Institute Inc. share price of $5.26 per share as on July 17, 2026 at 1:29 am IST.

What is the minimum amount required to buy The Oncology Institute Inc. Stock (TOI) from India?

Indian investors can start investing in The Oncology Institute Inc. (TOI) shares with as little as ₹96.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.35 in The Oncology Institute Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on The Oncology Institute Inc. share’s latest price of $5.26 as on July 17, 2026 at 1:29 am IST, you will get 1.9011 shares of The Oncology Institute Inc.. Learn more about fractional shares .